Showing results (111-120 of 217) with videos related to

Sort By:
Pageof 22
IJU Case Reports|July 3, 2025
An Excellent Clinical and Radiological Response Pattern to Pembrolizumab in a Patient With Metastatic Adrenocortical Carcinoma and Lynch SyndromeYuki Shimozawa, Yosuke Yasuda, Emiko Sugawara, et al.
Urology|October 22, 2013
The processus vaginalis transection method to prevent postradical prostatectomy inguinal hernia: long-term resultsYasuhisa Fujii, Shinya Yamamoto, Junji Yonese, et al.
American Journal of Cancer Research|March 26, 2019
ADP-ribosylation factor-like 4C is a predictive biomarker of poor prognosis in patients with renal cell carcinomaTakahiro Isono, Tokuhiro Chano, Tetsuya Yoshida, et al.
IJU Case Reports|January 4, 2024
A case of neoadjuvant chemotherapy-resistant muscle-invasive bladder cancer that markedly responded to pembrolizumab before conversion radical cystectomyIchiro Yonese, Noboru Numao, Kentaro Inamura, et al.
International Journal of Clinical Oncology|September 12, 2024
Efficacy and safety of adjuvant nivolumab after radical surgery for high-risk urothelial carcinoma: a preliminary report of real-world data from a single institutionYosuke Yasuda, Noboru Numao, Tetsuya Urasaki, et al.
Prostate Cancer and Prostatic Diseases|February 9, 2021
Tumor B7-H3 expression in diagnostic biopsy specimens and survival in patients with metastatic prostate cancerGulanbar Amori, Emiko Sugawara, Yasuyuki Shigematsu, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2004
Efficacy of the third-generation bisphosphonate, zoledronic acid alone and combined with anti-cancer agents against small cell lung cancer cell linesSeiji Matsumoto, Shinya Kimura, Hidekazu Segawa, et al.
BMC Urology|March 12, 2014
Organ-specific and tumor-size-dependent responses to sunitinib in clear cell renal cell carcinomaNorihiko Tsuchiya, Takeshi Yuasa, Shinya Maita, et al.
Urologia Internationalis|August 29, 2019
Incidence and Predictors of Deep Vein Thrombosis in Patients with Elevated Serum D-Dimer Prior to Surgery for Urologic MalignancyRyo Fujiwara, Noboru Numao, Yudai Ishikawa, et al.
Clinical Genitourinary Cancer|July 9, 2020
Cisplatin, Gemcitabine, and Paclitaxel as a Salvage Second-Line Therapy for Metastatic Germ-Cell CancerMotohiro Fujiwara, Tatsuro Hayashi, Hayato Takeda, et al.
Pageof 22